To target appropriate drug concentrations and to facilitate comparisons between drugs, the potency of propofol must be firmly established. We therefore determined the arterial blood propofol concentration preventing movement in 50% of patients after skin incision and the ability of arterial blood pressure and heart rate to predict movement after incision. Fifteen healthy women scheduled for breast surgery were randomly assigned to computer-targeted propofol blood concentrations. No other drugs were administered. Fifteen minutes after starting the propofol infusion, a 5-cm skin incision was made. Patients were observed for gross purposeful movement for 1 min. Arterial blood was sampled for propofol to confirm steady-state blood concentrations. Arterial blood pressure and heart rate were measured noninvasively. Logistic regression was used to calculate the propofol blood concentrations and arterial blood pressures at which 50% and 95% of patients did not move after skin incision (CT', and Cl?,,, MABP,, and MABP,,, respectively). The CT',, and CP,, values for propofol were 14.3 2 1.6 pg/mL (mean ? SE) and 20.6 pg/mL, respectively. The MABP,, and MABP,, values were 63 -C 4 mm Hg and 43 mm Hg, respectively. Heart rate did not differ significantly in patients who moved and who did not move. Propofol blood concentrations required to prevent movement in most patients resulted in significant arterial hypotension.
To target appropriate drug concentrations and to facilitate comparisons between drugs, the potency of propofol must be firmly established. We therefore determined the arterial blood propofol concentration preventing movement in 50% of patients after skin incision and the ability of arterial blood pressure and heart rate to predict movement after incision. Fifteen healthy women scheduled for breast surgery were randomly assigned to computer-targeted propofol blood concentrations. No other drugs were administered. Fifteen minutes after starting the propofol infusion, a 5-cm skin incision was made. Patients were observed for gross purposeful movement for 1 min. Arterial blood was sampled for propofol to confirm steady-state blood concentrations. Arterial blood pressure and heart rate were measured noninvasively. Logistic regression was used to calculate the propofol blood concentrations and arterial blood pressures at which 50% and 95% of patients did not move after skin incision (CT', and Cl?,,, MABP,, and MABP,,, respectively) . The CT',, and CP,, values for propofol were 14.3 2 1.6 pg/mL (mean ? SE) and 20.6 pg/mL, respectively. The MABP,, and MABP,, values were 63 -C 4 mm Hg and 43 mm Hg, respectively. Heart rate did not differ significantly in patients who moved and who did not move. Propofol blood concentrations required to prevent movement in most patients resulted in significant arterial hypotension. (Anesth Analg 1997; 85:414-9) P ropofol is now commonly used for the induction and maintenance of anesthesia (1). Its use as a maintenance drug may increase further with the advent of computer-controlled infusion pumps, which establish and maintain constant propofol blood concentrations (2-6). Firmly establishing the potency of propofol will facilitate targeting of appropriate blood concentrations (7) and allow potency comparisons with other drugs.
Potency is traditionally defined by the arterial blood concentration required to prevent movement in 50% of the study population (Cl',,) . Researchers use prevention of movement in response to painful stimulation as a measure of potency because it is an "all-ornone" response, which is easily measured in both animals and humans (8). The Cl',, of propofol, as a sole drug has been determined only once before, by Smith et al. (4) , and was reported to be 15.2 pg/mL. This value is surprisingly high, because far lower concentrations are routinely used in clinical practice. Several aspects of their study protocol possibly contributed to the high propofol blood concentrations required to prevent movement. Endeavoring to comply with the requirements for the measurement of anesthetic potency (8), we therefore determined the CP,, of propofol in healthy female patients undergoing breast biopsy.
Monitors of pharmacodynamic effect may be applied as an alternative to targeting specific propofol blood concentrations (9, 10). This strategy avoids the difficulties of trying to predict actual propofol blood concentrations.
Arterial blood pressure and heart rate are measured frequently in all anesthetized patients, and clinicians use these measurements in an attempt to predict patient responses to incision and to adjust anesthetic depth accordingly.
We reported previously that arterial blood pressure, but not heart rate, predicted movement after painful stimulation in volunteers anesthetized with propofol and nitrous oxide (10). Accordingly, we evaluated the ability of arterial blood pressure and heart rate to predict movement after skin incision and compared them with the propofol blood concentration.
Methods
With approval from the Board of Medical Research at the Royal Melbourne Hospital, we studied 15 consenting female patients, aged 42 + 12 yr (mean ? SD), weighing 66 t 11 kg, ASA physical status I or II, scheduled for semielective breast biopsy. The following patients were excluded from the study: 1) excessively obese or thin patients; 2) those with any condition, or who were taking any medication, known to affect anesthetic requirement;
3) those requiring endotracheal intubation; and 4) those with any significant cardiovascular, respiratory, renal, or hepatic disease. Patients were randomly assigned to receive a target propofol blood concentration of 6, 8, 10, 12, 14, 16, 18 , or 20 pg/mL. The minimum concentration was chosen because the propofol blood concentration required to ensure loss of consciousness in 95% of human volunteers is 5.4 pg/mL (4), whereas the maximum concentration was chosen based on potential hemodynamic effects of high propofol concentrations (11). The lean body mass (LBM) of each patient was determined from height (Ht) and total body mass (TBM), using a formula adapted to female gender: LBM = (1.07 * TBM) -1148 * (TBM/Ht)'l (12). No premeditation was given. A 16-gauge catheter was inserted into an ante-cubital vein, and lactated Ringer's solution (10 mL/kg bolus, then 10 mL * kg-i * h-i) was administered.
Local anesthetic was injected intradermally over the radial artery, in preparation for blood sampling for propofol assay. Patients breathed 100% oxygen via a circle system for 5 min. Anesthesia then was induced and maintained by a stepped intravenous (IV) infusion of propofol (Diprivana; ICI Pharmaceuticals, Macclesfield, Cheshire, England), delivered by a Gemini PCl@ infusion pump (Imed Corporation, San Diego, CA) operating in Versataper@ mode. This mode allows a series of constant-rate infusions of varying duration to be delivered automatically. The pharmacokinetic data used to program the pump were derived from a previous study of propofol pharmacokinetics during mild hypothermia in young healthy volunteers (13). Combined data from hypothermic and normothermic volunteers were used to program the infusion pump, using the method of Plasma Drug Efflux (14). Patients received no other anesthetics or other drugs, and continued to breathe 100% oxygen, gently assisted if necessary to maintain an end-tidal carbon dioxide tension of 35-40 mm Hg.
Fifteen minutes after starting the infusion, an investigator called the patient's name, tapped her gently on the shoulder, and asked her to open her eyes. When loss of responsiveness was documented, the surgeon made a 5-cm skin incision in the appropriate breast. Gross purposeful movement of the head or limbs in the first minute after the incision was defined as a positive response. Truncal movement, facial movement, and chewing or coughing were not considered positive responses. Thereafter, the anesthetic proceeded routinely. After recovery from anesthesia, patients were questioned to assess recall of intraoperative events.
Arterial blood pressure, heart rate, hemoglobin oxygen saturation, and end-tidal carbon dioxide tension were recorded 5 and 3 min before and 0,5,10,15, and 16 min during infusion of propofol (Capnomac Ulti-@ and Cardiocap@ Rtlandl).
To confirm steady-state propofol blood concentrations before the incision, blood was taken from the dominant radial artery 10 and 15 min after the start of the infusion. A third sample was taken at 16 min (i.e., 1 min after incision) to confirm steady-state concentrations during assessment of responsiveness.
Blood samples for the propofol assay were collected in heparinized tubes, placed on ice, and subsequently stored at 4°C for up to 10 wk. Propofol blood concentrations decreased at less than 0.2% per week at 4°C. They were subsequently analyzed using a highperformance liquid chromatography assay, modified from the method of Plummer (15). This assay is linear to at least 20 mg/L and has a detection limit of 0.025 mg/L and a coefficient of variation of 4.1% at 2 mg/L.
Linear regression with residual analysis was used to correlate target and measured propofol blood concentrations, and mean arterial blood pressure, heart rate, and measured propofol blood concentration.
The differences in propofol blood concentration, mean arterial blood pressure, and heart rate between movers and nonmovers were analyzed using unpaired twotailed t-tests.
Response to skin incision (movement or no movement) was analyzed using logistic regression to determine the propofol blood concentrations that prevent movement in 50% (Cl',,) and 95% (Cl',,) of the population. The mean arterial blood pressures at the 50% (MABP,,) and 95% (MABP,,) nonresponse levels were similarly determined.
Ability of propofol blood concentration, mean arterial blood pressure, and heart rate to predict movement was evaluated using prediction probability (I',), a type of nonparametric correlation that can compare the performance of indicators having different units of measurement.
The mathematical basis of I', was described by Smith et al. (16) . Numerically, I', is the probability that an indicator predicts correctly which of a pair of randomly selected stimuli, one causing movement and the other not, will cause movement. (f = 0.75, P = 0.00002).
An indicator that predicts perfectly whether a movement response will occur has a I', value of 1.0, whereas an indicator that performs no better than chance has a I', value of 0.5. The predictive performances iI', values) of propofol blood concentration and mean arterial blood pressure were compared using a paired-data jackknife analysis, as there was correlation between propofol blood concentration and mean arterial blood pressure (16). As there was no correlation between heart rate and mean arterial blood pressure or propofol blood concentration, a grouped-data jackknife analysis was used. Jackknifing is a method of estimating the misclassification rate of a discriminant function. This method obtains an estimate of the true misclassification rate by classifying each of the cases using a discriminant function from whose calculation the case in question has been excluded. For multiple comparisons, we used the Bonferroni method. Results are presented as means + SD, unless specified otherwise; P < 0.05 was considered statistically significant.
Results
No patient recalled any intraoperative event. Measured propofol blood concentrations were within 14% t 12% (range -46% 2 24%) of target concentrations. Measured concentrations were related to target concentrations by the equation: measured [propofol] = 1.03 * target [propofoll (r2 = 0.75, P = 0.00002) ( Figure  1) .
Measured propofol blood concentrations during the study varied by 8% t 5% (range -19% + 13%) between 10 and 15 min, 7% + 6% (range -21% ? 15%) between 10 and 16 min, and 6% + 3% (range -11% t 9%) between 15 and 16 min. Blood samples for propofol assay were not obtained in two patients at 16 min (Figure 2 ). Propofol blood concentrations before incision were significantly less in patients who moved than in those who did not: 10.2 + 2.8 pg/mL (range 6.4-15.4 pg/ mL) vs 16.6 ? 4.2 pg/mL (range 7.6-20.0 pg/mL) (P = 0.005). Mean arterial blood pressure values before incision were significantly greater in patients who moved than those in patients who did not: 73 + 15 mm Hg (range 58-100 mm Hg) vs 52 t 11 mm Hg (range 39-67 mm Hg) (P = 0.007). However, heart rates before incision did not differ significantly in patients who moved and in those who did not move: 84 + 12 bpm (range 74-100 bpm) vs 77 + 16 bpm (range 58-109 bpm) (P = 0.35) (Figures 3-5) .
The probability 8) value of movement at a measured propofol blood concentration was described by:
where tunh = hyperbolic tangent function, a = -0.234 + 0.13 and [prop] = measured propofol blood concentration. The Cl',, of propofol was 14.3 + 1.6 pg/mL (mean ? SE) and the Cl',, was 20.6 pg/mL (Figure 3) .
Similarly, the following equation described the probability of movement at a measured MABP:
where b = 0.0752 rf 0.054. MABP,, was 63 f 4 mm Hg (mean ? SE), and the MABP,, 'was 43 mm Hg ( Figure  4) . It was not possible to relate heart rate and the probability of movement using logistic regression ( Figure 5 ). Prediction probability (Px) values were calculated to determine the relative performance of propofol blood concentration, mean arterial blood pressure, and heart rate. I', values for propofol blood concentration, mean arterial blood pressure, and heart rate were 0.87 + 0.11,0.88 + 0.09, and 0.66 t 0.16 (mean t mean arterial blood pressure were thus significantly better at predicting movement than heart rate, but they were not different from each other. MABP was related to propofol blood concentration by the equation: MABP = -1.8 * [propofol] + 87 (r;? = 0.32; P = 0.03). In contrast, there was no significant relation between heart rate and propofol blood concentration (r;? = 0) (Figure 6 ). + 87 (12 = 0.32, P = 0.03). In contrast, there was no significant relation between heart rate and propofol blood concentration (u2 = 0).
Discussion
The CP,, of propofol after skin incision in this study was 14.3 + 1.6 pg/mL. This result is similar to the result of 15.2 pg/mL reported by Smith et al. (4) . We expected our result to be significantly less, as we avoided stimulating patients before determining the Cl',, and used a standardized incision. In the study of Smith et al. (4) , skin incisions were made at various sites and were possibly of variable size. Unless a supramaximal stimulus is delivered, response intensity varies with the degree of stimulation. Furthermore, patients were given succinylcholine and had their tracheas intubated shortly before incision. Tracheal intubation provokes catecholamine release, which not only results in vasodilation and perfusion of nonneuronal tissue, but also causes central nervous system arousal, which increases anesthetic requirement (17). Finally, arterial hypotension refractory to volume therapy was treated with ephedrine. Ephedrine is the only vasopressor known to increase anesthetic requirement (18). Despite attempts to improve the study design, our result was within 10% of the result of ANALG 1997; 85:414-9 Smith et al. (4). We conclude that rigorously standardizing the painful stimulus or reducing additional stimulation may be unnecessary in future studies. Although the CP,, is traditionally used in studies as a measure of anesthetic potency, the Cl',, is more relevant in clinical practice, as clinicians must adequately anesthetize all their patients, not just half of them. Therefore, if propofol is used alone, and movement after incision must be prevented, infusion rates sufficient to achieve a blood concentration of 20.6 pg/mL must be delivered. (At steady state, a blood concentration of 20.6 pg/mL is maintained by propofol infusion at approximately 800 pg * kg-' * min-'1. In our study, it was not possible to achieve these blood concentrations without simultaneous arterial hypotension (mean arterial blood pressure at Cl?,, was 43 mm Hg). Arterial hypotension of this severity may not be tolerated well, even by healthy patients. Alternative strategies are obviously required. One strategy is to administer propofol in combination with other anesthetics that decrease arterial blood pressure less. Propofol blood concentrations required to prevent movement after painful incision are decreased significantly by fentanyl (41, alfentanil (6), nitrous oxide (lo), and temazepam (19). These adjuvants may have less deleterious effects on arterial blood pressure than propofol. Further studies may be warranted.
Another strategy is to support the circulation. Propofol produces arterial hypotension by a combination of factors: 1) a reduction in central sympathetic output (20); 2) resetting of baroreflex activity (21); 3) direct peripheral venodilation (22); and possibly 4) decreased myocardial contractility (23). Administering IV fluids before induction of anesthesia or using vasopressors may limit decreases in blood pressure. However, substantial fluid loading in our patients failed to prevent significant arterial hypotension.
A final strategy is to abandon prevention of movement as a goal of anesthesia, and instead target more clinically relevant anesthetic effects, which are suppressed by lesser anesthetic concentrations, and which produce less serious hemodynamic consequences. The state of general anesthesia involves suppressing a great variety of somatic and autonomic responses (24). These anesthetic effects may arise as separate pharmacological actions of one drug or a drug combination (25). For example, anesthetics probably prevent movement after painful stimulation via a subcortical action (26). Hemodynamic responses also have a subcortical origin. Suppression of the spontaneous electroencephalograph (EEG) and prevention of consciousness and recall, however, likely represent a cortical anesthetic action. These effects usually occur at lesser anesthetic concentrations than those required to prevent movement or hemodynamic responses (11). (EEG burst suppression was likely at Cl',, and Cl',, in our study.) Thus, movement after painful stimulation may occur despite EEG burst suppression during anesthesia (27, 28) . We conclude that absence of recall and unconsciousness are more appropriate targets than prevention of movement during propofol anesthesia.
The CP,,-awake of propofol is 5.4 pg/mL (4), a quarter the concentration required to prevent movement, whereas concentrations required to prevent learning are even less (9). In addition, amnesic wakefulness and recall are abolished at similar anesthetic concentrations (29). These data suggest that propofol blood concentrations of 6-8 pg/mL are adequate if muscle relaxants are used to prevent movement.
In the absence of computer-controlled infusion pumps that can accurately target blood concentrations, or online concentration analysis, it is more convenient to predict responsiveness using monitors of anesthetic effect. Hemodynamic variables are used extensively in clinical practice and in research (30) as measures of anesthetic depth, despite the fact that their predictive performance under all conditions is not firmly established (31). In our patients, mean arterial blood pressure, but not heart rate, predicted movement as well as propofol blood concentration. This is consistent with our previous report that arterial blood pressure and propofol concentration, but not heart rate, predicted movement after painful stimulation in volunteers anesthetized with propofol and nitrous oxide (10).
In addition, we confirm previous reports (32) that blood pressure changes during propofol anesthesia are concentration-dependent.
Therefore, arterial blood pressure probably acts as a surrogate for propofol blood concentration as a predictor of movement, rather than hypotension decreasing anesthetic requirement itself. It remains likely, however, that arterial blood pressure would prove less predictive in patients with hemodynamic instability, hypovolemic patients, or patients undergoing different surgical procedures. It is also likely that blood pressure predicts movement less reliably for painful stimuli subsequent to the initial incision. Finally, we cannot advocate using arterial blood pressure to predict movement when such profound hypotension is required. The strategies discussed above must be considered as alternatives.
Our computer-controlled propofol infusion produced adequately accurate and constant propofol blood concentrations.
Pharmacokinetic data used to program the infusion were derived from a group of volunteers of similar age and body morphology to the patients in this study. The effects of body morphology were further reduced by using lean tissue mass to calculate dosage. Hysteresis between blood and effectsite concentrations was minimized by allowing at least 15 minutes (>3 times the half-time for equilibration with the effect compartmenti) for equilibration before testing.
We sampled blood by direct arterial puncture. Each separate puncture may have caused patient arousal, but we believe that using local anesthesia prevented this potential problem. In any case, endotracheal intubation, as used by Smith et al. (4) , is a greater noxious stimulus than needle puncture (33).
In conclusion, we report that the CP,, for propofol is 14.3 ? 1.6 &mL.
This result is similar to that obtained by Smith et al. (4) in the only other comparable study. We also report that in healthy women anesthetized with propofol, arterial blood pressure, but not heart rate, predicts movement after surgical incision. 
